C90.1

Clinical Causes: Genetic mutations in plasma cells that lead to abnormal proliferation Previous history of multiple myeloma or other plasma cell disorders Genetic predispositions or familial factors Exposure to certain chemicals or radiation (though rare) Age-related genetic changes, with higher incidence in older adults

Key Symptoms: Weakness and fatigue, often due to anemia Unintentional weight loss Bone pain or fractures resulting from bone involvement Enlarged liver or spleen (organomegaly) Increased susceptibility to infections Bleeding or easy bruising due to low platelet counts Elevated calcium levels causing confusion, constipation, or muscle weakness Swelling in the legs or ankles

Diagnosis Path: Identifying plasma cell leukemia involves a combination of laboratory and clinical assessments, including: - Blood tests revealing abnormal plasma cells circulating in the blood - Bone marrow biopsy showing an excess of malignant plasma cells - Blood chemistry tests to evaluate calcium, kidney function, and other markers - Imaging studies such as X-rays, MRI, or CT scans to assess bone damage or organ involvement - Protein studies like serum and urine protein electrophoresis to detect abnormal antibodies A definitive diagnosis is usually made when a high number of plasma cells are present in the bloodstream, often exceeding 20% of the total white blood cell count.

Treatment Protocols: Managing plasma cell leukemia typically involves a combination of therapies aimed at controlling disease progression and alleviating symptoms: - Chemotherapy to target rapidly dividing cancer cells - Targeted therapies and immunotherapies that focus on specific genetic markers - Corticosteroids to reduce inflammation and cancer cell growth - Stem cell transplant, possibly following initial treatment to replace diseased bone marrow - Supportive care including transfusions, antibiotics, and medication to manage symptoms - Clinical trials exploring new treatments offer additional options for some patients Because of its aggressive nature, treatment plans are often tailored individually, and their success varies depending on various factors such as patient age and overall health.